The three studies investigating statin chemoprevention in this review exclusively modeled the progression of triple-negative breast cancer (TNBC), an aggressive form of breast cancer histologically known for absent to low concentrations of estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) protein receptors. This evidence concerns the gene ESR1 and breast cancer.